Reducing the Risk of Recurrence In HR+/HER2- Early Breast Cancer Requires Action: MDT Clinical Case Discussions episode artwork

EPISODE · Sep 25, 2021 · 33 MIN

Reducing the Risk of Recurrence In HR+/HER2- Early Breast Cancer Requires Action: MDT Clinical Case Discussions

from Keeping Current CME

Join a multidisciplinary panel for a discussion on current evidence for identifying and managing HR+/HER2- early breast cancer. Credit available for this activity expires: 9/24/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/959685?src=mkm_podcast_addon_959685

Episode metadata supplied by the publisher feed · Published Sep 25, 2021

Embed this episode

NOW PLAYING

Reducing the Risk of Recurrence In HR+/HER2- Early Breast Cancer Requires Action: MDT Clinical Case Discussions

0:00 33:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 33 minutes long.

When was this Keeping Current CME episode published?

This episode was published on September 25, 2021.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!